{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:28Z","timestamp":1786979608973,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T00:00:00Z","timestamp":1322092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00103-011-1374-2","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T11:58:13Z","timestamp":1322135893000},"page":"1325-1331","source":"Crossref","is-referenced-by-count":12,"title":["Substanzinduzierte Schlafst\u00f6rungen und Schlafmittelmissbrauch","Substance-induced sleep disorders and abuse of hypnotics"],"prefix":"10.1007","volume":"54","author":[{"given":"D.","family":"Riemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,24]]},"reference":[{"key":"1374_CR1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.pneurobio.2004.06.004","volume":"73","author":"Basheer","year":"2004","unstructured":"Basheer R, Strecker RE, Thakkar MH, McCarley RW (2004) Adenosine and sleep-wake regulation. Prog Neurobiol 73:379\u2013396","journal-title":"Prog Neurobiol"},{"key":"1374_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.smrv.2007.07.004","volume":"12","author":"Roehrs","year":"2008","unstructured":"Roehrs T, Roth T (2008) Caffeine: sleep and daytime sleepiness. Sleep Med Rev 12:153\u2013162","journal-title":"Sleep Med Rev"},{"key":"1374_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.smrv.2009.04.002","volume":"14","author":"Riemann","year":"2010","unstructured":"Riemann D, Spiegelhalder K, Feige B et al (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14:19\u201331","journal-title":"Sleep Med Rev"},{"key":"1374_CR4","unstructured":"DHS (2010) Jahrbuch Sucht. Neuland Verlagsgesellschaft mbh, Geesthacht"},{"key":"1374_CR5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.smrv.2008.12.003","volume":"13","author":"Jaehne","year":"2009","unstructured":"Jaehne A, Loessl B, Barkai Z et al (2009) Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Med Rev 13:363\u2013377","journal-title":"Sleep Med Rev"},{"key":"1374_CR6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00115-003-1637-8","volume":"75","author":"Gann","year":"2004","unstructured":"Gann H, Calker D van, Feige B, Riemann D (2004) Die Bedeutung des Schlafs f\u00fcr gesunde Alkoholkonsumenten und alkoholabh\u00e4ngige Patienten. Nervenarzt 75:431\u2013441","journal-title":"Nervenarzt"},{"key":"1374_CR7","unstructured":"National Institute on Drug Abuse (2006) Monitoring the future. National results on adolescent drug use. Overview of key findings 2006. Online, cited 2007, Sep 10, 76 screens. http:\/\/www.monitoringthefuture.org\/"},{"key":"1374_CR8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.smrv.2007.12.004","volume":"12","author":"Schierenbeck","year":"2008","unstructured":"Schierenbeck T, Riemann D, Berger M, Hornyak M (2008) Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev 12:381\u2013390","journal-title":"Sleep Med Rev"},{"key":"1374_CR9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000441-199004000-00004","volume":"299","author":"Dahl\u00f6f","year":"1990","unstructured":"Dahl\u00f6f C, Dimen\u00e4s E (1990) Side effects of beta-blocker treatments as related to the central nervous system. Am J Med Sci 299:236\u2013244","journal-title":"Am J Med Sci"},{"key":"1374_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(90)90092-G","volume":"46","author":"McAinsh","year":"1990","unstructured":"McAinsh J, Cruickshank JM (1990) Beta-blockers and central nervous system side effects. Pharmacol Ther 46:163\u2013197","journal-title":"Pharmacol Ther"},{"key":"1374_CR11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0013-4694(85)91107-1","volume":"60","author":"Kanno","year":"1985","unstructured":"Kanno O, Clarenbach P (1985) Effect of clonidine and yohimbine on sleep in man: polygraphic study and EEG analysis by normalized slope descriptors. Electroencephalogr Clin Neurophysiol 60(6):478\u2013484","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"1374_CR12","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/0024-3205(87)90471-1","volume":"41","author":"Monti","year":"1987","unstructured":"Monti JM (1987) Disturbances of sleep and wakefulness associated with the use of antihypertensive agents. Life Sci 41:1979\u20131988","journal-title":"Life Sci"},{"key":"1374_CR13","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1210\/jc.2004-1056","volume":"90","author":"Buckley","year":"2005","unstructured":"Buckley TM, Schatzberg AF (2005) On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90:3106\u20133114","journal-title":"J Clin Endocrinol Metab"},{"key":"1374_CR14","unstructured":"Van Cauter E, Turek FW (1995) Endocrine and other biological rhythms. In: De Groot LJ (Hrsg) Endocrinology, 3. Aufl. Saunders, Philadelphia, S\u00a02497\u20132548"},{"key":"1374_CR15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.npp.1300362","volume":"29","author":"Friess","year":"2004","unstructured":"Friess E, Tagaya H, Grethe C et al (2004) Acute cortisol administration promotes sleep intensity in man. Neuropsychopharmacology 29:598\u2013604","journal-title":"Neuropsychopharmacology"},{"key":"1374_CR16","doi-asserted-by":"crossref","first-page":"R555","DOI":"10.1152\/ajpcell.1998.275.2.C555","volume":"275","author":"Bradbury","year":"1998","unstructured":"Bradbury MJ, Dement WC, Edgar DM (1998) Effects of adrenalectomy and subsequent corticosterone replacement on rat sleep state and EEG power spectra. Am J Physiol 275:R555\u2013R565","journal-title":"Am J Physiol"},{"key":"1374_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","volume":"20","author":"McDonough","year":"2008","unstructured":"McDonough AK, Curtis JR, Saag KG (2008) The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 20:131\u2013137","journal-title":"Curr Opin Rheumatol"},{"key":"1374_CR18","unstructured":"Cairns BE (2007) Pain medication and sleep quality. In: Lavigne G, Sessle BJ, Choiniere M, Soja PJ (Hrsg) Sleep and pain. IASP press, Seattle, S\u00a0371\u2013390"},{"key":"1374_CR19","unstructured":"Agargun MY, Ozbek H (2006) Drug effects on dreaming. In: Lader M, Cardinali DP, Pandi-Perumal SR (Hrsg) Sleep and sleep disorders: a neuropsychopharmacological approach. Landes Bioscience\/Eurekah.com and Springer Science\u2009+\u2009Business Media, New York, S\u00a0256\u2013261"},{"key":"1374_CR20","unstructured":"Riemann D, Voderholzer U (2003) Der gest\u00f6rte Schlaf: Via regia zum Verst\u00e4ndnis depressiver Erkrankungen. Uni-Med., Bremen"},{"key":"1374_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5664\/jcsm.27716","volume":"6","author":"Hoque","year":"2010","unstructured":"Hoque R, Chesson AL (2010) Pharmacologically induced\/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder\/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 6:79\u201383","journal-title":"J Clin Sleep Med"},{"key":"1374_CR22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00115-009-2746-9","volume":"80","author":"Riemann","year":"2009","unstructured":"Riemann D, Hajak G (2009) Insomnien. II. Pharmakologische und psychotherapeutische Behandlungsm\u00f6glichkeiten. Nervenarzt 80:1327\u20131340","journal-title":"Nervenarzt"},{"key":"1374_CR23","unstructured":"Benkert O, Hippius H (2007) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg New York Tokyo"},{"key":"1374_CR24","doi-asserted-by":"crossref","unstructured":"Mendelson WB (2005) Hypnotic medications: mechanisms of action and pharmacological effects. In: Kryger MH, Roth T, Dement WC (Hrsg) Principles and practice of sleep medicine, 4. Aufl. Elsevier Saunders, Philadelphia PA, S\u00a0444\u2013451","DOI":"10.1016\/B0-72-160797-7\/50043-4"},{"key":"1374_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.smrv.2008.06.001","volume":"13","author":"Riemann","year":"2009","unstructured":"Riemann D, Perlis ML (2009) The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 13:205\u2013214","journal-title":"Sleep Med Rev"},{"key":"1374_CR26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/sleep\/26.7.793","volume":"26","author":"Krystal","year":"2003","unstructured":"Krystal AD, Walsh JK, Laska E et al (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26:793\u2013799","journal-title":"Sleep"},{"key":"1374_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/sleep\/31.1.79","volume":"31","author":"Krystal","year":"2008","unstructured":"Krystal AD, Erman M, Zammit GK et al (2008) Long-term efficacy and safety of zolpidem extended-release 12,5\u00a0mg, administered 3\u20137 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79\u201390","journal-title":"Sleep"},{"key":"1374_CR28","first-page":"225","volume":"162","author":"Holbrook","year":"2000","unstructured":"Holbrook AM, Crowther R, Lotter A et al (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162:225\u2013233","journal-title":"CMAJ"},{"key":"1374_CR29","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"Glass","year":"2005","unstructured":"Glass J, Lanctot KL, Herrmann N et al (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331:1169\u20131175","journal-title":"BMJ"},{"key":"1374_CR30","doi-asserted-by":"crossref","unstructured":"Hippius H, Engel RR, Laakmann G (1986) Benzodiazepine \u2013 R\u00fcckblick und Ausblick. Springer, Berlin Heidelberg New York Tokyo","DOI":"10.1007\/978-3-642-70621-9"},{"key":"1374_CR31","doi-asserted-by":"crossref","unstructured":"Hajak G, R\u00fcther E (1995) Insomnie. Springer, Berlin Heidelberg New York Tokyo","DOI":"10.1007\/978-3-662-12085-9"},{"key":"1374_CR32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00002018-200326040-00004","volume":"26","author":"Terzano","year":"2003","unstructured":"Terzano MG, Rossi M, Palomba V et al (2003) New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 26:261\u2013282","journal-title":"Drug Saf"},{"key":"1374_CR33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00023210-200418050-00003","volume":"18","author":"Vermeeren","year":"2004","unstructured":"Vermeeren A (2004) Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 18:297\u2013328","journal-title":"CNS Drugs"},{"key":"1374_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/157488606775252674","volume":"1","author":"Verster","year":"2006","unstructured":"Verster JC, Veldhuijzen DS, Patar A et al (2006) Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Saf 1:63\u201371","journal-title":"Curr Drug Saf"},{"key":"1374_CR35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/ijerph6031041","volume":"6","author":"Verster","year":"2009","unstructured":"Verster JC, Mets MA (2009) Psychoactive medication and traffic safety. Int J Environ Res Public Health 6:1041\u20131054","journal-title":"Int J Environ Res Public Health"},{"key":"1374_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/archpsyc.59.2.131","volume":"59","author":"Kripke","year":"2002","unstructured":"Kripke DF, Garfinkel I, Wingard DL (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131\u2013136","journal-title":"Arch Gen Psychiatry"},{"key":"1374_CR37","doi-asserted-by":"crossref","unstructured":"Kripke DF (2006) Risks of chronic hypnotic use. In: Lader M, Cardinali DP, Pandi-Perumal SR (Hrsg) Sleep and sleep disorders \u2013 a neuropsychopharmacologuical approach. Springer, New York, S\u00a0141\u2013145","DOI":"10.1007\/0-387-27682-3_15"},{"key":"1374_CR38","unstructured":"Schwabe U, Pfaffrath D (2008) Arzneiverordnungsreport 2008. Springer, Berlin"},{"key":"1374_CR39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00115-008-2648-2","volume":"80","author":"Hoffmann","year":"2009","unstructured":"Hoffmann F, Scharfetter W, Glaeske G (2009) Use of zolpidem and zopiclone on private prescriptions between 1993 and 2007. Nervenarzt 80:578\u2013583","journal-title":"Nervenarzt"},{"key":"1374_CR40","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pds.2013","volume":"19","author":"Hoffmann","year":"2010","unstructured":"Hoffmann F, Hies M, Gl\u00e4ske G (2010) Regional variations of private prescriptions for the non-benzodiazepine hypnotics zolpidem and zopiclone in Germany. Pharmacoepidemiol Drug Saf 19:1071\u20131077","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1374_CR41","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","volume":"98","author":"Hajak","year":"2003","unstructured":"Hajak G, M\u00fcller WE, Wittchen HU et al (2003) Abuse and depen-dence potential for the non-benzodiazepine hypnotics Zolpidem and Zopiclone \u2013 a review of case reports and epidemiological data. Addiction 98:1371\u20131378","journal-title":"Addiction"},{"key":"1374_CR42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1024\/2007.04.02","volume":"53","author":"Lange","year":"2007","unstructured":"Lange K, Wodarz N, Hajak G (2007) Abh\u00e4ngigkeitspotential der GABAa-Rezeptor-agonistischen Nichtbenzodiazepin-Hypnotika. Sucht 53:201\u2013213","journal-title":"Sucht"},{"key":"1374_CR43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2125.2007.02861.x","volume":"64","author":"Victorri-Vigneau","year":"2007","unstructured":"Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P (2007) Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64:198\u2013209","journal-title":"Br J Clin Pharmacol"},{"key":"1374_CR44","unstructured":"Kr\u00e4mer K, Nolting HD (2010) Gesundheitsreport 2010 \u2013 DAK. Medhochzwei, Heidelberg"},{"key":"1374_CR45","unstructured":"Gl\u00e4ske G (2010) Medikamente \u2013 Psychotrope und andere Arzneimittel mit Missbrauchs- und Abh\u00e4ngigkeitspotential. Jahrbuch Sucht (DHS) Neuland Verlagsgesellschaft mbH, Geesthacht, S\u00a069\u201395"},{"key":"1374_CR46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0447.1994.tb01563.x","volume":"90","author":"Hohagen","year":"1994","unstructured":"Hohagen F, K\u00e4ppler C, Schramm E et al (1994) Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand 90:102\u2013108","journal-title":"Acta Psychiatr Scand"},{"key":"1374_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0031-1275303","volume":"44","author":"Riemann","year":"2011","unstructured":"Riemann D, Spiegelhalder K, Espie C et al (2011) Chronic insomnia: clinical and research challenges \u2013 an agenda. Pharmacopsychiatry 44:1\u201314","journal-title":"Pharmacopsychiatry"},{"key":"1374_CR48","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2165\/0003495-200868170-00001","volume":"68","author":"Wiegand","year":"2008","unstructured":"Wiegand M (2008) Antidepressants for the treatment of insomnia \u2013 A suitable approach? Drugs 68:2411\u20132417","journal-title":"Drugs"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-011-1374-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-011-1374-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-011-1374-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T20:12:19Z","timestamp":1593288739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-011-1374-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,24]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1007\/s00103-011-1374-2","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,24]]}}}